Prostatis Group’s iShares Silver Trust SLV Stock Holding History

Prostatis Group’s Portfolio SLV Stock Details SLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Buy	5,320 +922	+21%	+$61.1K	0.07%	144
2026 Q1	$300K	Buy	4,398 +236	+6%	+$17.9K	0.08%	141
2025 Q4	$268K	Sell	4,162 -1,289	-24%	-$64.5K	0.06%	145
2025 Q3	$231K	Buy	+5,451	New	+$196K	0.06%	155
2023 Q3	–	Sell	-13,307	Closed	-$70.2K	–	214
2023 Q2	$70.2K	Buy	+13,307	New	+$296K	0.03%	154
2023 Q1	–	Sell	-25,321	Closed	-$558K	–	110
2022 Q4	$558K	Buy	+25,321	New	+$496K	0.34%	58

Other funds holding SLV

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CTC (Chicago Trading Company) Chicago, Illinois $316B AUM 71.57% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Prostatis Group's SLV Position: Q2 2026 in Review

Prostatis Group increased its iShares Silver Trust (SLV) stake by 21% in Q2 2026, buying an estimated $61.1K and bringing the position to 5,320 shares worth $284K. The position accounts for 0.07% of the portfolio, ranked #144.

Prostatis Group first reported a position in SLV in Q4 2022 and has held it in 6 quarters since. The position peaked at $558K in Q4 2022. 1,427 funds tracked by Wall St. Rank hold SLV as of Q2 2026.

Prostatis Group held 5,320 shares of iShares Silver Trust worth $284K as of Q2 2026.
Prostatis Group bought 922 iShares Silver Trust shares in Q2 2026, an estimated $61.1K.
iShares Silver Trust made up 0.07% of Prostatis Group's portfolio in Q2 2026, its #144 holding.
Prostatis Group first reported a position in iShares Silver Trust in Q4 2022 and has held it in 6 quarters since.
Prostatis Group's iShares Silver Trust position peaked at $558K in Q4 2022.
1,427 funds tracked by Wall St. Rank held iShares Silver Trust as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.